meningococcus

(redirected from Neisseria meningitidis)
Also found in: Medical, Acronyms, Encyclopedia, Wikipedia.
Related to Neisseria meningitidis: Neisseria gonorrhoeae

me·nin·go·coc·cus

 (mə-nĭng′gə-kŏk′əs, -nĭn′jə-)
n. pl. me·nin·go·coc·ci (-kŏk′sī, -kī)
A bacterium (Neisseria meningitidis) that causes cerebrospinal meningitis.

me·nin′go·coc′cal (-kŏk′əl), me·nin′go·coc′cic (-kŏk′sĭk) adj.

meningococcus

(mɛˌnɪŋɡəʊˈkɒkəs)
n, pl -cocci (-ˈkɒkaɪ)
(Medicine) the bacterium that causes cerebrospinal meningitis

me•nin•go•coc•cus

(məˌnɪŋ goʊˈkɒk əs)

n., pl. -coc•ci (-ˈkɒk saɪ, -si)
a spherical or kidney-shaped bacterium, Neisseria meningitidis, that causes cerebrospinal meningitis.
[1890–95; < New Latin]
me•nin`go•coc′cal, me•nin`go•coc′cic (-ˈkɒk ɪk, -ˈkɒk sɪk) adj.
Translations

me·nin·go·coc·cus

n. meningococo, uno de los microorganismos causantes de la meningitis cerebral epidémica.

meningococcus

n (pl -ci) meningococo
Mentioned in ?
References in periodicals archive ?
Neisseria meningitidis can be classified into 12 serogroups, although the vast majority of infections are caused by just six of these: A, B, C, W, X and Y (Harrison et al, 2009).
is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B.
Deficiency of the sixth component of complement and susceptibility to Neisseria meningitidis infections.
The agreement gives sanofi pasteur exclusive, world-wide rights to Emergent BioSolutions' proprietary proteins and related technology for the development of a novel vaccine to protect against Neisseria meningitidis serogroup B bacterial infections.
Three years ago, people from more than a dozen countries in Africa, Asia, Europe, and North America became infected with the W-135 strain of Neisseria meningitidis after Muslim pilgrims unknowingly carried it home from the annual Hajj in Mecca, Saudi Arabia.
Deerfield, IL) has patented chemically-modified group B polysaccharides of Neisseria meningitidis.
Meningitec[TM], which is a vaccine for the prevention of invasive disease caused by Neisseria meningitidis serogroup C.
Neisseria meningitidis bacteria are a leading cause of bacterial meningitis and other serious invasive bacterial infections.
To the Editor: Neisseria meningitidis is an exclusive human pathogen causing serious disease worldwide resulting in rapid mortality, and is associated with large epidemics every 5-10 years.
While the evidence is now clear that the level of protective antibody against Neisseria meningitidis drops to suboptimal levels 5 years after receipt of MCV4, the level of disease does not appear to have been affected yet.
In many people, Neisseria meningitidis resides quietly in the nose or throat, doing no harm.